154 related articles for article (PubMed ID: 36551672)
1. Development of Monoclonal Antibodies Targeting Canine PD-L1 and PD-1 and Their Clinical Relevance in Canine Apocrine Gland Anal Sac Adenocarcinoma.
Minoli L; Licenziato L; Kocikowski M; Cino M; Dziubek K; Iussich S; Fanelli A; Morello E; Martano M; Hupp T; Vojtesek B; Parys M; Aresu L
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551672
[TBL] [Abstract][Full Text] [Related]
2. PD-1, PD-L1, and PD-L2 Gene Expression and Tumor Infiltrating Lymphocytes in Canine Melanoma.
Stevenson VB; Perry SN; Todd M; Huckle WR; LeRoith T
Vet Pathol; 2021 Jul; 58(4):692-698. PubMed ID: 34169800
[TBL] [Abstract][Full Text] [Related]
3. Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate.
Cascio MJ; Whitley EM; Sahay B; Cortes-Hinojosa G; Chang LJ; Cowart J; Salute M; Sayour E; Dark M; Sandoval Z; Mitchell DA; Milner RJ
Vet Immunol Immunopathol; 2021 Feb; 232():110169. PubMed ID: 33387703
[TBL] [Abstract][Full Text] [Related]
4. Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for Immunotherapy.
Yanik EL; Kaunitz GJ; Cottrell TR; Succaria F; McMiller TL; Ascierto ML; Esandrio J; Xu H; Ogurtsova A; Cornish T; Lipson EJ; Topalian SL; Engels EA; Taube JM
JAMA Oncol; 2017 Jul; 3(7):974-978. PubMed ID: 28334399
[TBL] [Abstract][Full Text] [Related]
5. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F
Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216
[TBL] [Abstract][Full Text] [Related]
6. Canine Apocrine Gland Anal Sac Adenocarcinoma: A Review.
Repasy AB; Selmic LE; Kisseberth WC
Top Companion Anim Med; 2022; 50():100682. PubMed ID: 35792243
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma.
Maekawa N; Konnai S; Okagawa T; Nishimori A; Ikebuchi R; Izumi Y; Takagi S; Kagawa Y; Nakajima C; Suzuki Y; Kato Y; Murata S; Ohashi K
PLoS One; 2016; 11(6):e0157176. PubMed ID: 27276060
[TBL] [Abstract][Full Text] [Related]
8. Histopathological diagnosis and surgical complications following bilateral anal sacculectomy for the treatment of unilateral canine apocrine gland anal sac adenocarcinoma: 35 cases (2019-2023).
Franca A; Stamenova P; Thompson JL
J Small Anim Pract; 2024 Apr; ():. PubMed ID: 38594872
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma.
Urie BK; Russell DS; Kisseberth WC; London CA
BMC Vet Res; 2012 May; 8():67. PubMed ID: 22630170
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Canine Apocrine Gland Anal Sac Adenocarcinoma (AGASACA) Tumor Specimen Shrinkage after Formalin Fixation.
Wustefeld-Janssens BG; Vinayak A; Parker LA; Hollenbeck DL
Animals (Basel); 2022 Jul; 12(15):. PubMed ID: 35892519
[TBL] [Abstract][Full Text] [Related]
11. Detection of human epidermal growth factor receptor 2 overexpression in canine anal sac gland carcinoma.
Yoshimoto S; Kato D; Kamoto S; Yamamoto K; Tsuboi M; Shinada M; Ikeda N; Tanaka Y; Yoshitake R; Eto S; Saeki K; Chambers JK; Kinoshita R; Uchida K; Nishimura R; Nakagawa T
J Vet Med Sci; 2019 Jul; 81(7):1034-1039. PubMed ID: 31142682
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of prostaglandin EP4 receptor in three canine carcinomas.
Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM
BMC Vet Res; 2020 Jun; 16(1):213. PubMed ID: 32571310
[TBL] [Abstract][Full Text] [Related]
13. Post-operative complications following apocrine gland anal sac adenocarcinoma resection in dogs.
Sterman A; Butler JR; Chambers A; Dickson R; Dornbusch J; Mickelson M; Selmic L; Scharf V; Schlag A; Skinner O; Vinayak A; Janssens BW
Vet Comp Oncol; 2021 Dec; 19(4):743-749. PubMed ID: 34173318
[TBL] [Abstract][Full Text] [Related]
14. Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases.
Harter PN; Bernatz S; Scholz A; Zeiner PS; Zinke J; Kiyose M; Blasel S; Beschorner R; Senft C; Bender B; Ronellenfitsch MW; Wikman H; Glatzel M; Meinhardt M; Juratli TA; Steinbach JP; Plate KH; Wischhusen J; Weide B; Mittelbronn M
Oncotarget; 2015 Dec; 6(38):40836-49. PubMed ID: 26517811
[TBL] [Abstract][Full Text] [Related]
15. Combined Positive Score for Programmed Death Ligand-1 Expression and Inflammatory Microenvironment in Gastrointestinal Stromal Tumors.
Herlea V; Roșulescu A; Calotă VC; Croitoru V; Stoica Mustafa E; Vasilescu C; Alexandrescu S; Dumitrașcu T; Popescu I; Dima SO; Sajin M
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208498
[No Abstract] [Full Text] [Related]
16. Comparison of methods to determine primary tumour size in canine apocrine gland anal sac adenocarcinoma.
Schlag AN; Johnson T; Vinayak A; Kuvaldina A; Skinner OT; Wustefeld-Janssens BG
J Small Anim Pract; 2020 Mar; 61(3):185-189. PubMed ID: 31960434
[TBL] [Abstract][Full Text] [Related]
17. Apocrine gland anal sac adenocarcinoma in cats: 30 cases (1994-2015).
Amsellem PM; Cavanaugh RP; Chou PY; Bacon NJ; Schallberger SP; Farese JP; Kuntz CA; Liptak JM; Culp WTN; Robat CS; Powers BE
J Am Vet Med Assoc; 2019 Mar; 254(6):716-722. PubMed ID: 30835176
[TBL] [Abstract][Full Text] [Related]
18. Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes.
Zhu Q; Cai MY; Chen CL; Hu H; Lin HX; Li M; Weng DS; Zhao JJ; Guo L; Xia JC
Oncoimmunology; 2017; 6(5):e1312240. PubMed ID: 28638740
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating lymphocytes status, programmed death-ligand 1 expression, and clinicopathological features of 41 cases of pure apocrine carcinoma of the breast: a retrospective study based on clinical pathological analysis and different immune statuses.
Xiao X; Jin S; Zhangyang G; Xiao S; Na F; Yue J
Gland Surg; 2022 Jun; 11(6):1037-1046. PubMed ID: 35800740
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of dogs with apocrine gland anal sac adenocarcinoma treated via modified closed anal sacculectomy (2015-2022).
Davey EL; Prpich CY
Vet Surg; 2024 Mar; ():. PubMed ID: 38477012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
